Investigation of melanocortin system gene variants in antipsychotic-induced weight gain

Nabilah I Chowdhury1, Renan P Souza, Arun K Tiwari

  • 1Neurogenetics Section, Neuroscience Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health , Toronto, ON , Canada.

Abstract

Insights

Genetic variants in POMC, CART, and AGRP genes do not appear to significantly contribute to antipsychotic-induced weight gain (AIWG) in schizophrenia patients. Further research with larger sample sizes is needed to definitively confirm these findings.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Second-generation antipsychotics can cause significant weight gain in schizophrenia patients.
  • Hypothalamic neurons expressing CART, POMC, and AGRP play key roles in regulating body weight and energy balance.

Purpose of the Study:

  • To investigate the potential association between genetic variants in CART, POMC, and AGRP genes and antipsychotic-induced weight gain (AIWG).

Main Methods:

  • Genotyping of specific single nucleotide polymorphisms (SNPs) in CART, POMC, and AGRP genes in 218 chronic schizophrenia patients undergoing antipsychotic treatment.
  • Analysis of covariance was used to compare weight change (%) across different genotypic groups.

Main Results:

  • No significant associations were found between the studied SNPs in POMC, CART, or AGRP and AIWG.
  • This lack of association remained consistent after stratifying samples by ethnicity and medication treatment.

Conclusions:

  • Exploratory findings suggest that variants in POMC, CART, and AGRP genes are not major contributors to AIWG.
  • Larger sample sizes are necessary to conclusively rule out the influence of these gene variants on AIWG.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.8K
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
1.3K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138